Aditxt, Inc. Debt Instrument, Redemption Price, Percentage
Aditxt, Inc. (ADTX) reported Debt Instrument, Redemption Price, Percentage of 125.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2026-03-31
- Aditxt, Inc. debt instrument, redemption price, percentage for the quarter ending 2024-03-31 was 25.00%.
- Aditxt, Inc. debt instrument, redemption price, percentage for fiscal 2025 was 125.00%.
| Period end | Debt Instrument, Redemption Price, Percentage 3 month | Debt Instrument, Redemption Price, Percentage 12 month |
|---|---|---|
| 2025-12-31 | 125.00% 10-K · filed 2026-03-31 | |
| 2024-03-31 | 25.00% 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |